1. Home
  2. NPB vs CTKB Comparison

NPB vs CTKB Comparison

Compare NPB & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NPB
  • CTKB
  • Stock Information
  • Founded
  • NPB 1999
  • CTKB 1990
  • Country
  • NPB United States
  • CTKB United States
  • Employees
  • NPB N/A
  • CTKB N/A
  • Industry
  • NPB
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • NPB
  • CTKB Health Care
  • Exchange
  • NPB NYSE
  • CTKB Nasdaq
  • Market Cap
  • NPB 463.9M
  • CTKB 450.9M
  • IPO Year
  • NPB 2025
  • CTKB 2021
  • Fundamental
  • Price
  • NPB $13.07
  • CTKB $2.95
  • Analyst Decision
  • NPB Buy
  • CTKB Hold
  • Analyst Count
  • NPB 2
  • CTKB 4
  • Target Price
  • NPB $17.25
  • CTKB $6.00
  • AVG Volume (30 Days)
  • NPB 82.6K
  • CTKB 1.6M
  • Earning Date
  • NPB 01-01-0001
  • CTKB 08-05-2025
  • Dividend Yield
  • NPB 0.19%
  • CTKB N/A
  • EPS Growth
  • NPB 273.19
  • CTKB N/A
  • EPS
  • NPB 1.94
  • CTKB N/A
  • Revenue
  • NPB $195,582,000.00
  • CTKB $197,050,000.00
  • Revenue This Year
  • NPB $27.37
  • CTKB $0.91
  • Revenue Next Year
  • NPB $13.48
  • CTKB $7.75
  • P/E Ratio
  • NPB $6.74
  • CTKB N/A
  • Revenue Growth
  • NPB N/A
  • CTKB N/A
  • 52 Week Low
  • NPB $11.43
  • CTKB $2.37
  • 52 Week High
  • NPB $14.98
  • CTKB $7.63
  • Technical
  • Relative Strength Index (RSI)
  • NPB N/A
  • CTKB 42.71
  • Support Level
  • NPB N/A
  • CTKB $3.16
  • Resistance Level
  • NPB N/A
  • CTKB $3.72
  • Average True Range (ATR)
  • NPB 0.00
  • CTKB 0.20
  • MACD
  • NPB 0.00
  • CTKB 0.01
  • Stochastic Oscillator
  • NPB 0.00
  • CTKB 30.07

About NPB NORTHPOINTE BANCSHARES INC

Northpointe Bancshares Inc operates its business through its wholly-owned banking subsidiary, Its lending focus is the origination of residential mortgages throughout the United States. The majority of these loans are sold in the secondary market through a network of investors. The Company has also developed mortgage advance program that provides funding to pre-approved mortgage bankers who originate and sell individual conforming and non-qualified loan products in the secondary market. The Company continues to service loans that were originated and sold to investors as well as loans held in its portfolio which were originated and selectively held in portfolio.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: